• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here

Category

All
  • Alle
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News
  • Congress News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE
Pharma News

FDA’s priority review to quizartinib for FLT-3 mutant AML patients

subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Advancements in thrombophilia testing: The role of multi-gene panels in venous thromboembolism
  • The role of UBTF-TD mutations in paediatric acute myeloid leukaemia and myelodysplastic syndrome
  • Desensitisation as treatment option in patients with drug hypersensitivity
  • HMB-001: Novel treatment for Glanzmann thrombasthenia
  • Anti-IL6 receptor antibody for the treatment of immune checkpointrelated hemophagocytic lymphohistiocytosis
  • Highlights from EBMT 2025
  • Journal scan
  • New haematology reimbursements in Belgium
Pharma News

FDA’s decision on gene therapy Roctavian for adults with haemophilia A in early 2023  

Clinical trials

No survival benefit from adding gilteritinib to azacitidine in newly-diagnosed FLT3-mutated pa...

Clinical trials

Ivosidenib plus azacitidine for patients with IDH1-mutated acute myeloid leukaemia

Clinical practice

Long-term remission rates after treatment with tisagenlecleucel in paediatric and young adult ...

Clinical trials

Encouraging results with loncastuximab tesirine plus rituximab for DLBCL patients

Clinical trials

Prolonged PFS with zanubrutinib in untreated CLL/SLL patients

Previous 14 15 16 17 18 19 20 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025